Viewing Study NCT00829192

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2026-02-03 @ 1:52 AM
Study NCT ID: NCT00829192
Status: UNKNOWN
Last Update Posted: 2010-12-06
First Post: 2009-01-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II AK Study in Organ Transplant Patients
Sponsor: Clinuvel Pharmaceuticals Limited
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Actinic Keratoses View
None Carcinoma, Squamous Cell View
None Organ Transplant Recipients View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Actinic keratoses (AK) View
None Squamous cell carcinomas (SCC) View
None CUV1647 View
None Afamelanotide View
None Clinuvel View
None Photoprotection View
None Organ transplant View